565 filings
8-K
SNOA
Sonoma Pharmaceuticals Inc.
9 Apr 24
Regulation FD Disclosure
7:30am
8-K
SNOA
Sonoma Pharmaceuticals Inc.
2 Apr 24
Sonoma Pharmaceuticals, Inc. Investor Presentation April 2024
7:30am
8-K
SNOA
Sonoma Pharmaceuticals Inc.
22 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
SNOA
Sonoma Pharmaceuticals Inc.
8 Mar 24
Entry into a Material Definitive Agreement
4:29pm
424B3
SNOA
Sonoma Pharmaceuticals Inc.
8 Mar 24
Prospectus supplement
4:27pm
8-K
xtslgju68d42i uf9lud
10 Jan 24
Sonoma Pharmaceuticals, Inc. Investor Presentation January 2024
7:30am
8-K
0qm89qwomorly6
9 Jan 24
Entry into a Material Definitive Agreement
4:47pm
8-K
2qpyngop
29 Dec 23
Departure of Directors or Certain Officers
5:23pm
8-K
flbz4pk52hyeo
15 Dec 23
Entry into a Material Definitive Agreement
6:14pm
424B3
bl2qb1g9ny
15 Dec 23
Prospectus supplement
5:30pm
424B5
ufvco51
22 Nov 23
Prospectus supplement for primary offering
4:30pm
EFFECT
zzqj1h7aofwe60czilm
21 Nov 23
Notice of effectiveness
12:15am
CORRESP
99d9w9lb58dq
17 Nov 23
Correspondence with SEC
12:00am
UPLOAD
sql8aunpdm5
7 Nov 23
Letter from SEC
12:00am
424B4
l5rapsx34urq51lg
30 Oct 23
Prospectus supplement with pricing info
7:30am
EFFECT
rqbzik5ng 9z
27 Oct 23
Notice of effectiveness
12:15am
CORRESP
qzy4emgmooog6lkgf0j
24 Oct 23
Correspondence with SEC
12:00am